HK Stock Market Move | LONGCHEER (09611) rose more than 7% and the acquisition of Approved Jiecheng was officially completed. Institutions point out that the company's business is expected to extend downstream to consumer electronics.
Longqi Technology (09611) surged more than 7%, as of the time of writing, it rose by 7.09% to HKD 24.46, with a turnover of HKD 8.43 million.
LONGCHEER (09611) rises more than 7%, as of the time of publication, it has risen by 7.09% to HK$24.46, with a turnover of HK$8.4329 million.
On the news front, recently, LONGCHEER announced the acquisition of 60% equity of Kejuancheng Precision and Jiya Metal (the target company) respectively. The prerequisites stated in the equity transfer agreement have been met, and the transfer of equity and relevant amendments to the articles of association of the target company have been completed by the relevant local market supervision authorities. Therefore, the acquisition is expected to be completed on June 12, 2026 (the delivery date). After the completion of the acquisition, the company, Mr. Wu Yutao, Mr. Xiong Dao'an, and the employee incentive platform directly hold 60%, 18.8%, 17.2%, and 4.0% of the shares of each target company respectively.
Changjiang stated that Kejuancheng is a leading domestic high-precision metal etching technology manufacturer, with end customers including major consumer electronics brands in North America. Its net profit reached 133 million yuan in 2025, a substantial year-on-year increase. The acquisition by LONGCHEER this time not only enriches customer resources, but also enters the high-growth heat dissipation track, with potential for expansion from downstream consumer electronics to other applications in the future.
Related Articles

HK Stock Market Move | CNBM (03323) rose more than 9% in early trading, with increases in fiberglass and electronic fabric prices being smoothly passed on. Institutions point out that CNBM has a leading advantage.

HK Stock Market Move | HENLIUS (02696) rose nearly 4% as the commercialization of the targeted therapy drugs BILDYOS and TUZEMTY in Canada began.

Guosen: How do multinational medical device companies view the Chinese market?
HK Stock Market Move | CNBM (03323) rose more than 9% in early trading, with increases in fiberglass and electronic fabric prices being smoothly passed on. Institutions point out that CNBM has a leading advantage.

HK Stock Market Move | HENLIUS (02696) rose nearly 4% as the commercialization of the targeted therapy drugs BILDYOS and TUZEMTY in Canada began.

Guosen: How do multinational medical device companies view the Chinese market?

RECOMMEND





